baber/WOPTO huggingface dataset:
Patent AU-685944-B2 (AU)
Title: Device and process for combining and processing several paper webs
Inventor: SCHWEIGER JOSEPH
IPC: B41F13/02
Filed: 1995-04-13
Granted: 1998-01-29
Abstract: PCT No. PCT/EP95/01402 Sec. 371 Date Oct. 15, 1996 Sec. 102(e) Date Oct. 15, 1996 PCT Filed Apr. 13, 1995 PCT Pub. No. WO95/28345 PCT Pub. Date Oct. 26, 1995A device for combining and processing at least two paper or foil webs includes at least two pay-out units (1a, 1b, 1c), in each of which a paper web (3a, 3b, 3c) provided with markings applied at regular intervals is pulled off by withdrawal rolls (7a, 8a, 7b, 8b, 7c, 8c) from a roll (2a, 2b, 2c) and, possibly guided over deflection rollers (13a, 13b, 13c), is combined with the at least second paper web (3a, 3b, 3c) and fed to a processing line (11). In processing line (11) preferably the at least two paper webs (3a, 3b, 3c), possibly independent of one another, pass through processing units and are supplied to a unit (15) for further processing. Means are provided for congruent longitudinal register control of the at least two paper webs (3a, 3b, 3c), said means comprising means for producing a paper tension that is essentially the same for each of the at least two paper webs (3a, 3b, 3c), over the width of the respective paper web, web feelers (18, 17a, 17b, 17c) for registering the time sequence of the markings on each paper web (3a, 3b, 3c), and a control unit (19) for controlling a drive or brake device. Withdrawal rolls, especially in the form of rubber rolls (14a, 14b), are provided as means for developing paper tension, said rolls being located downstream of processing line (11) and preferably directly upstream of unit (15) for further processing.
Patent AU-680765-B2 (AU)
Title: Method of installing looped backed carpet
Inventor: PACIONE JOSEPH ROCCO
IPC: A47G27/04
Filed: 1995-05-16
Granted: 1997-08-07
Abstract: A method of installing a looped backed carpet is disclosed in which water is applied to the carpet, the carpet is allowed to expand, and the carpet is then affixed in place by a hook and loop system in its expanded state.
Patent AU-741249-B2 (AU)
Title: Air classifier with centrifugal action
Inventor: CORDONNIER ALAIN
IPC: B07B4/06
Filed: 1997-04-15
Granted: 2001-11-29
Abstract: A centrifugal type pneumatic separator having a rotor and a housing. The rotor has a plurality of vanes distributed around a periphery thereof. The housing contains the rotor. The housing has an air input conduit, a material input conduit and an evacuation conduit. The air input conduit passes air through channels formed between adjacent vanes such that air and material flows toward the evacuation conduit. The rotor is divided so as to define at least two separate passages whereby air from the air input conduit flows toward the evacuation conduit as two separate and parallel streams.
Patent AU-754917-B2 (AU)
Title: Implant comprising calcium cement and hydrophobic liquid
Inventor: BOHNER MARC
IPC: A61L27/44
Filed: 1999-02-02
Granted: 2002-11-28
Abstract: A composition including a hydraulic cement for implantation in a human or animal body. The hydraulic cement includes a first component, a second component, and a third component. The first component includes a calcium source while the second component includes water. The third component is a hydrophobic liquid. The composition hardens after mixing of the components, and results in a cement with open macroporosity enabling a rapid bone ingrowth.
Patent AU-664218-B2 (AU)
Title: Oral hygiene products
Inventor: DUCKWORTH RALPH MARSLAND
IPC: A61K8/73
Filed: 1992-12-09
Granted: 1995-11-09
Abstract: The present invention relates to oral hygiene products in the form of liquid mouthwash compositions which comprise a particulate therapeutic agent which is stably suspended in the liquid mouthwash compositions. It has now been found that a single system can be obtained by stably suspending the particulate therapeutic agent in a liquid medium which contains specific polymers, which are selected from the group consisting of proteinaceous polymers, polysaccharidic polymers, copolymers of vinylpyrolidone with an acrylic monomer, and mixtures thereof, said polymers having an average molecular weight of 1,000,000 or less. Typical examples of suitable polymers are gelatin and Polymer JR, and a typical example of a suitable particulate therapeutic agents is magnesium fluoride.
Patent AU-761437-B2 (AU)
Title: Method of reducing staining of stannous in dentifrice compositions
Inventor: GLANDORF WILLIAM MICHAEL
IPC: A61K8/24
Filed: 1999-11-23
Granted: 2003-06-05
Abstract: Disclosed are methods for reducing the staining of dentifrice composition containing stannous comprising admnistering to a subject the dentifrice composition. The dentifrice composition is a dual phase dentifrice and is contained in physically separated compartments of a dentifrice dispenser. The first dentifrice composition comprises an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and has a total water content of up to about 20%. The second dentifrice composition comprises an effective amount of stannous ions. The molar ratio of polyphosphate anion to stannous ion is from about 0.2:1 to about 5:1 and the efficacy of the stannous ion in the dentifrice is not reduced by the polyphosphate. The dentifrice composition may alternatively be a single phase dentifrice. The single phase dentifrice will comprise an effective amount of one or more linear polyphosphates having an average chain length of about 4 or more and an effective amount of a stannous anion. The single phase dentifrice has a total water content of up to about 20%, the stannous ion is not delivered from stannous fluoride, a molar ratio of polyphosphate anion to stannous ion is from about 0.2:1 to about 5:1, and the efficacy of the stannous ion in the dentifrice is not reduced by the polyphosphate.
Patent AU-621097-B2 (AU)
Title: A synthetic antigen evoking anti-hiv response
Inventor: BERZOFSKY JAY A
IPC: G01N33/60
Filed: 1989-01-17
Granted: 1992-03-05
Abstract: A synthetic oligopeptide which evokes anti-HIV response has been prepared. The oligopeptide is useful as a vaccine and as a diagnostic, prognostic and therapeutic agent in cases of HIV infection.
Patent AU-550914-B2 (AU)
Title: Optical fibre preform manufacture
Inventor: ROBA GIACOMO
IPC: C03B37/018
Filed: 1984-09-12
Granted: 1986-04-10
Abstract: The process allows a uniform layer of glass particles, forming the preform, to be deposited on the internal wall of a supporting tube rotated around its axis. A suitable relationship is provided to determine the temperature distribution in the deposition zone. The apparatus makes use of different types of heat sources for generating inside the tube a temperature with the distribution required by the process.
Patent AU-573626-B2 (AU)
Title: Protein/polysaccharide complexes as wound dressing
Inventor: EASTON IAN ALEXANDER
IPC: C08H1/06
Filed: 1984-10-03
Granted: 1988-06-16
Abstract: @ Complexes of polyanionic plant polysaccharides with biodegradable proteins, or proteolytic degradation products thereof, are useful in the formation of wound dressings and surgical implants, such as sutures, blood vessel grafts, and artificial organs. The biodegradable protein is preferably collagen, and the polysaccharide is preferably sodium alginate. The complexes are preferably formed by combining the protein and the polysaccharide at a pH which is no higher than the isoelectric point of the protein. The complexes may be crosslinked, such as by dehydrothermal crosslinking or by the use of chemical crosslinking agents such as aldehydes or carbodiimides. Multivalent cations may also be incorporated in the complex in order to give added strength.
Patent AU-615294-B2 (AU)
Title: Crew oxygen mask with pneumatic comfort adjustment
Inventor: AULGUR CHARLES C
IPC: A62B7/14
Filed: 1989-02-21
Granted: 1991-09-26
Abstract: A respirator especially constructed for flight crews has a harness strap which can be inflated to a somewhat rigid, self-sustaining orientation to permit one-handed placement of the respirator over the wearer's head. Once the respirator is in place, release of a lever for inflating the strap deflates the latter to an orientation sufficient to cause the resilient strap to tightly press a peripheral seal of the respirator mask against nose and mouth areas of the user's face. A comfort adjustment to relieve strap tension permits selective reinflation of the strap to a somewhat smaller value than necessary for initial donning of the harness, and the limited reinflation pressure is sufficient for causing the mask to seal against the face during pressure demand breathing. In instances where pressurized breathing is needed, however, pressure within the strap is automatically released so that the strap presents sufficient bias to hold the mask against the face without oxygen leakage therepast.
Patent AU-668148-B2 (AU)
Title: Packing material
Inventor: HURWITZ MICHAEL
IPC: B65D81/09
Filed: 1993-03-16
Granted: 1996-04-26
Abstract: A filling material (10) for use in filling hollow spaces in packaging or the like comprising one or more pieces of flexible paper material (12). The paper material has a plurality of individual slits (14, 16) formed in parallel spaced rows extending transversely from one end of the paper material to the opposing end of the paper material. The slits in adjacent alternate rows are positioned adjacent the interval space (20) between adjacent slits in the adjacent parallel row of slits. The flexible paper material (12) is expandable by extending the opposing ends (22, 24) of the paper material which are parallel to the rows of slits whereby the slits form an array of openings, each opening being generally hexagonal in shape and of the same size. The length and width of the flexible filling paper material can be varied. The construction of the flexible paper filling material provides it to be easily stored in the non-expandable position and easily expanded for use in filling hollow spaces in packaging.
Patent AU-772633-B2 (AU)
Title: Echinocandin/carbohydrate complexes
Inventor: LAREW LARRY ARNOLD
IPC: A61K47/38
Filed: 2000-03-02
Granted: 2004-05-06
Abstract: A complex of an echinocandin compound with a carbohydrate is described having improved thermal stability and water solubility. A process for making the echinocandin/carbohydrate complex is also described as well as the use of the complex in pharmaceutical formulations and treatments of fungal infections.
Patent AU-580289-B2 (AU)
Title: Microcapsules and microencapsulation process
Inventor: SCHER HERBERT BENSON
IPC: A01N25/28
Filed: 1985-03-20
Granted: 1989-01-12
Abstract: Novel microcapsules are disclosed in which a liquid material which is substantially insoluble in water is enclosed within a solid permeable shell of etherified urea-formaldehyde polymer, prepared by a process which comprises: (a) providing an organic solution comprising said material and a urea-formaldehyde prepolymer in which from about 50% to about 98% of the methylol groups of said prepolymer have been etherified with a C4-C10 alcohol; (b) creating an emulsion of said organic solution in an aqueous solution comprising water and a surface-active agent, wherein said emulsion comprises discrete droplets of said organic solution dispersed in said aqueous solution; (c) causing in situ self-condensation of said urea-formaldehyde prepolymers by adding to said emulsion an acidifying agent and maintaining said emulsion at a pH of between about 0 and about 4 for a sufficient period of time to allow substantial completion of in sttu condensation of said resin prepolymers to convert the liquid droplets of said organic solution to capsules consisting of solid permeable polymer shells enclosing said liquid material; and (d) heating said emulsion to a temperature between about 20 DEG C and about 100 DEG C to cause curing of said in situ formed polymers.
Patent AU-698861-B2 (AU)
Title: Device for use in transdermal perfusion procedures
Inventor: SVEDMAN PAL
IPC: A61B17/00
Filed: 1997-10-17
Granted: 1998-11-12
Abstract: Apparatus (301) is disclosed for use in sampling transdermal perfusion exudate from a de-epithelialised skin erosion. The apparatus comprises an enclosure defining a sampling chamber (307), securing means (306) operable to sealingly secure a contact surface of the enclosure to an area of skin peripheral to the erosion and an aperture (6) defined in the contact surface and communicating with the sampling chamber. The apparatus also comprises an outlet (310) which communicates with the sampling chamber for the outflow of exudate, an openable closure (311) for the outlet and means (309) for applying suction to the sampling chamber to enhance the rate at which exudate is produced.
Patent AU-583825-B2 (AU)
Title: An apparatus for recording a color video signal
Inventor: KAWAKAMI HIROSHI
IPC: H04N9/79
Filed: 1985-06-13
Granted: 1989-05-11
Abstract: An apparatus for recording a color video signal in which a luminance signal and a chrominance signal are recorded on separate channels and at least two chrominance component signals are compressed in timebase and alternately arranged in turn to be recorded on one track as the chrominance signal is disclosed. This apparatus includes timebase compressing and expanding circuits (30) provided respectively for the chrominance component signals and for producing timebase compressed chrominance component signals by writing the chrominance component signals by a first signal and by reading them by a second signal with the frequency integer times as high as that of the first signal and a coupling circuit (45) for simultaneously supplying the chrominance component signals, which are being read out from the output terminals of the timebase compressing and expanding circuits (30) by the second signal, to the input terminals of the timebase compressing and expanding circuits, whereby the timebase compressed chrominance component signals are written in the timebase compressing and expanding circuits by the second signal. In this case, when succeeding chrominance component signals are written in the timebase compressing and expanding circuits by the first signal, the timebase compressed chrominance component signals rewritten in the timebase compressing and expanding circuits are read out therefrom by the first signal so as to produce normal chrominance component signals.
Patent AU-583284-B2 (AU)
Title: A fountain brush
Inventor: PRESTELE ERICH
IPC: A46B7/02
Filed: 1985-07-15
Granted: 1989-04-27
Abstract: A washing brush contains a brush body with a central opening, that engages a cylindrical projection, which is positioned in the vicinity of the edge of a cover. The cover is in one piece with a gripping member, which can be connected to a water-carrying member. In the center of the cover and the brush body is provided an annular locking member, which passes through the cover within the liquid-carrying area in the form of a push button. By depressing the push button, it is possible to release the angular locking member between the gripping member and the brush body.
Patent AU-656482-B2 (AU)
Title: Excitatory amino acid receptor antagonists
Inventor: ARNOLD MACKLIN BRIAN
IPC: C07D401/06
Filed: 1993-08-31
Granted: 1995-02-02
Abstract: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof. The novel pharmaceutical compounds have the formula <CHEM>  wherein: R<1> is hydrogen, C1-C10 alkyl, arylalkyl, alkoxycarbonyl or acyl;  R<2> is hydrogen, C1-C6 alkyl, substituted alkyl, cycloalkyl, or arylalkyl;     R<3> is CO2H, SO3H, CONHSO2R<8>, or a group of formula <CHEM>   <CHEM>   <CHEM>     W is (CH2)n, S, SO, SO2;     Y is CHR<7>, NR<4>, O, S, SO, or SO2;     Z is NR<6>, CHR<7>, or CH; or W and Y together are HC=CH or C IDENTICAL C, or Y and Z together are HC=CH or C IDENTICAL C;     R<4> is hydrogen, C1-C4 alkyl, phenyl, or acyl; R<5> is hydrogen, C1-C4 alkyl, CF3, phenyl, hydroxy, amino, bromo, iodo, or chloro;     R<6> is acyl; R<7> is independently hydrogen, C1-C4 alkyl, phenyl, or substituted phenyl;     R<8> is C1-C4 alkyl or tetrazole-5-yl; and     n is 0, 1, or 2; provided that when Y is NR<4>, O, S, SO, or SO2, W is (CH2)n and Z is CHR<7> or CH; further provided that when W is S, SO, or SO2, Y is CHR<7>, Z is CHR<7> or CH, or Y and Z together are HC=CH or C IDENTICAL C;     further provided that when W and Z are CH2, Y is not S; further provided that when W and Y together are HC=CH or C IDENTICAL C, Z is CHR<7>; or a pharmaceutically acceptable salt thereof. 1,
Patent AU-524192-B2 (AU)
Title: Substituted 2-phenylamino-2-imidazolines
Inventor: STAHLE HELMUT
IPC: C07D233/50
Filed: 1979-07-18
Granted: 1982-09-02
Abstract: Compounds of the formula   <IMAGE>   wherein R1 and R2, which may be the same or different, represent a hydrogen atom, a chlorine atom, or a methyl group, with the proviso that not both R1 and R2 are hydrogen, and R represents a radical selected from the group consisting of -(CH2)2 -C(CH3)=CH2, -(CH2)2-CH=CH2, -O-CH2-CH=CH2, -O-(CH2)2-CH=CH2, -O-CH2-C(CH3)=CH2, -O-CH2-CH=CH-CH3,   <IMAGE> <IMAGE> +TR  <IMAGE>  and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.
Patent AU-589915-B2 (AU)
Title: Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents
Inventor: MOREIN BROR
IPC: A61K39/44
Filed: 1985-11-06
Granted: 1989-10-26
Abstract: The invention relates to a process for preparing an immunogenic complex comprising a carrier molecule prepared by mixing viruses, mycoplasmas, bacterias, animal cells or proteins or peptides having hydrophobic regions with one or more solubilizing agents, whereby a complex having been formed between proteins or peptides and solubilizing agents, whereafter the proteins or the peptides have been separated from the solubilizing agent in the presence of a glycoside solution which contains one or more glycosides having hydrophobic and hydrophilic regions in a concentration of at least the critical micellular concentration, or alternatively have been separated from the solubilizing agent and transferred directly to the aforementioned glycoside solution, and the carrier molecule being bound to one or more molecules selected from peptides, proteins, carbohydrates, lipoproteins, glycolipides or small molecules, such as biotine, by coupling with known methods between functional coupling groups in the bound molecules and functional groups in the peptides or the proteins in the carrier molecule. 
<??>The invention also relates to a method for preparing such immunogenic complexes, compositions, vaccines containing such complexes and to reagents.
Patent AU-783960-B2 (AU)
Title: Tek antagonists
Inventor: CERRETTI DOUGLAS P
IPC: A61K31/138
Filed: 2000-06-07
Granted: 2006-01-05
Abstract: The present invention provides Tek antagonists and methods of inhibiting angiogenesis in a mammal by administering Tek antagonists. The methods are particularly useful in treating diseases or conditions mediated by angiogenesis, such as solid tumors and diseases or conditions characterized by ocular neovascularization.
Patent AU-703283-B2 (AU)
Title: Dimer of molecular variant of apolipoprotein and processes for the production thereof
Inventor: CIRTORI CESARE
IPC: C07K1/18
Filed: 1996-07-12
Granted: 1999-03-25
Abstract: PCT No. PCT/SE92/00858 Sec. 371 Date Nov. 4, 1993 Sec. 102(e) Date Nov. 4, 1993 PCT Filed Dec. 11, 1992 PCT Pub. No. WO93/12143 PCT Pub. Date Jun. 24, 1993Substantially pure dimers of Apolipoprotein Al-Milano (Al-M/APO Al-M) isolated and characterized from plasma are provided. Pharmaceutical compositions comprising the Apo Al-M/Apo Al-M are also provided. Apolipoprotein Al-M dimer can be produced in a recombinant Escherichia coli system or collected from plasma from Apolipoprotein Al-Milano carriers. Atherosclerosis and cardiovascular diseases can be treated with the dimer. Medicaments containing the dimer can also be used for preventing thrombosis in different clinical circumstances, both at the arterial and at the venous level. The dimer can also act as a prodrug for the monomer.
Patent AU-727212-B2 (AU)
Title: Method and apparatus for delivering a cased glass stream
Inventor: SCOTT GARRETT L
IPC: C03B7/08
Filed: 1998-03-30
Granted: 2000-12-07
Abstract: Apparatus for forming a cased glass stream having an inner core of glass surrounded by an outer glass casing, includes (i) means for delivering core glass from a first source through a first orifice 22, (ii) means forming a second orifice 28 vertically below the first orifice with a chamber 30 surrounding the second orifice and communicating with the second orifice through a gap between the first and second orifices and (iii) means for delivering casing glass from a second source to the chamber such that glass flows by gravity through the orifices to form the cased glass stream. The first and second orifices are carried by an orifice housing assembly 44 with means for moving the assembly into seating engagement against the means for delivering core and casting glass so as to form an area seating engagement. The orifice housing assembly further includes a fluid manifold 50 mounted on the housing assembly and having inlet means for connection to a source of cooling fluid and outlet means 58 directed toward the area 59,60 of seating engagement between the assembly and the means for delivering core and casing glass for cooling the area and thereby reducing leakage of glass between the housing assembly and the means for delivering core and casing glass. Also claimed is an orifice housing assembly for an apparatus for forming a cased glass stream. Also claimed is a method of cooling the area of seating engagement between the orifice housing and the means for delivering streams of core and casing glass.
Patent AU-631914-B2 (AU)
Title: A method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
IPC: C07K5/06
Filed: 1990-08-10
Granted: 1992-12-10
Abstract: The invention relates to a method for the treatment of cardiac and of vascular hypertrophy and hyperplasia by administration of angiotensin converting enzyme inhibitors. Administration of compounds of the formula I   <IMAGE> (I)  in which n is 1 or 2, R, R1, R2 and R3 are identical or different and each is hydrogen or an organic radical, and R4 and R5 form, together with the atoms carrying them, a mono-, bi- or tricyclic heterocyclic ring system, is preferred. The invention additionally relates to angiotensin converting enzyme inhibitors and to agents containing these for administration for the treatment of the abovementioned diseases.
Patent AU-737619-B2 (AU)
Title: Process for the preparation of nicotinic acids
Inventor: SHARMA PADAM N
IPC: C07D213/82
Filed: 1998-02-18
Granted: 2001-08-23
Abstract: The present invention relates to an improved process for the preparation of nicotinic acids represented by the following structural formula (I):    <IMAGE>  I  which are prepared by reacting a nicotinic amide compound having the formula:   <IMAGE>   under acidic conditions with a nitrite salt. In the process of the invention have the groups R1, R2, and R3, in the compounds are independently selected from the group consisting of hydrogen, and halogen atoms and R4 is selected from the group consisting of hydrogen, lower alkyl and aryl. The process provides the nicotinic acid compounds in improved yields.